Search Results 821-830 of 19288 for hemoglobin

1. A Study to Evaluate the Safety and Effectiveness of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

   No hemoglobin decrease greater than 2.0 g/dL or an unexplained rising C-reactive protein (CRP), greater than 5.0 mg/L to a concentration above the ...

2. Biomarkers in Aortic Stenosis - B.A.S.S. - Mayo Clinic

   hemoglobin less than 8; severe valvular regurgitation; stenosis of the mitral valve. Participating Mayo Clinic locations. Study statuses change often. Please ...

3. A Study of the Effectiveness and Safety of CTL019 in Adult Patients with Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Hemoglobin > 8.0 g/dl. Must have an apheresis product of non-mobilized cells accepted for manufacturing; Women of child-bearing potential (defined as all ...

4. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   Hemoglobin ≥8.0 g/dL;; Total bilirubin ≤ 1.5 x ULN;; ALT and AST ≤ 2.5 x ULN. *Cockcroft-Gault Equation: Creatinine clearance for males = (140 - age)( ...

5. Study Of Chemotherapy Plus Ipatasertib For People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial - Mayo Clinic

   ... hemoglobin (Hb)A1c, suggesting poorly controlled diabetes - Participants who are on a stable dose of oral diabetes medication >= 2 weeks prior to initiation ...

6. Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer - Mayo Clinic

   Hemoglobin ≥ 11.5 g/dL;; Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN);; Alkaline phosphatase ≤ 1.5 x institutional upper limit of ...

7. A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma - Mayo Clinic

   Subject has absolute neutrophil count < 1000/μL, platelet count < 75,000/μL, and hemoglobin < 8 g/dL (< 5 mmol/L) at Screening; Subject has total serum ...

8. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

   Hemoglobin ≥ 7.0 g/dL (without transfusion or growth factor support within 14 days prior to registration). Absolute neutrophil count (ANC) ≥ 1,000 cells ...

9. A Study of MK-1026 in Patients with Selected Hematologic Malignancies - Mayo Clinic

   Hemoglobin (Hgb) ≥ 8.0 g/dL, stable for ≥ 1 week. For men and women of child-bearing potential, willing to use adequate contraception (e.g., latex condom ...

10. A Phase 2, Multicenter, Randomized Study of AP26113 - Mayo Clinic

    Hemoglobin ≥10 g/dL. Have Eastern Cooperative Oncology Group (ECOG) performance status ≤2. Have normal QT interval on screening electrocardiogram (ECG) ...